Panagiotis Velissarios Stamatakos

Evaluating early systemic therapies in the neoadjuvant setting for the treatment of urological cancers

INTRODUCTION: Neoadjuvant systemic therapy represents an evolving cornerstone in the multidisciplinary management of urological malignancies. While cisplatin-based neoadjuvant chemotherapy historically represented the sole standard of care for muscle-invasive bladder cancer, nove...